← Back to Calendar
Indication
Breast Oncology — Berlin, Germany
Key Notes
ESMO Breast Cancer Congress 2026: May 14–17, Berlin. Premier breast cancer data conference. Key presentations expected: oral SERD class updates (camizestrant, giredestrant, vepdegestrant), CDK4/6 inhibitor resistance data, ADC updates for HER2-low and TROP-2 programs. Directly relevant to multiple active PDUFA dates tracked on this calendar.
⚠️ Not Investment Advice: This information is provided for educational purposes only.
PDUFA dates are FDA target action dates, not guaranteed approval dates. The FDA may extend the review period,
issue Complete Response Letters, or take unexpected actions. Probability of approval scores are based on
historical base rates and do not account for drug-specific factors. Always consult a financial advisor
before making investment decisions.
Discussion
Share your analysis, research, or questions about this catalyst. No account required.